Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus
M. Azim Ansari(Centre for Human Genetics), Paolo Piazza(Centre for Human Genetics), David Bonsall(Centre for Human Genetics), George Nicholson(University of Oxford), Gilean McVean(Centre for Human Genetics), Camilla L. C. Ip(Centre for Human Genetics), Andrea Magrì(Centre for Human Genetics), Vincent Pedergnana(Université de Montpellier), Eleanor Barnes(Oxford Health NHS Foundation Trust), Paul Klenerman(John Radcliffe Hospital), John McLauchlan(MRC University of Glasgow Centre for Virus Research), Graham R. Foster(Queen Mary University of London), Amy Trebes(Centre for Human Genetics), István Bartha(SIB Swiss Institute of Bioinformatics), Peter Simmonds(University of Turku), Annette von Delft(University of Oxford), Jacques Fellay(SIB Swiss Institute of Bioinformatics), Emma Hudson(University of Oxford), David A. Smith(Compass Oncology), Nimisha Chaturvedi(Amsterdam UMC Location VUmc), G Cooke(Imperial College London)
Cited by 149
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k
Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
|Hepatology|2005|1.5k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k